BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32871048)

  • 1. LncRNA PITPNA-AS1 boosts the proliferation and migration of lung squamous cell carcinoma cells by recruiting TAF15 to stabilize HMGB3 mRNA.
    Ren P; Xing L; Hong X; Chang L; Zhang H
    Cancer Med; 2020 Oct; 9(20):7706-7716. PubMed ID: 32871048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.
    Peng BH; Ji YF; Qiu XJ
    J Clin Lab Anal; 2022 Jul; 36(7):e24506. PubMed ID: 35588441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HHIP-AS1 suppresses lung squamous cell carcinoma by stabilizing HHIP mRNA.
    Hu Z; Liu Y; Tang J; Luo R; Qin J; Mo Z; Xie J; Jiang X; Wei S; Lin C
    Life Sci; 2023 May; 321():121578. PubMed ID: 36958438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MIR9-3HG enhances LIMK1 mRNA and protein levels to contribute to the carcinogenesis of lung squamous cell carcinoma via sponging miR-138-5p and recruiting TAF15.
    Xiong Y; Yang C; Yang X; Ding C; Wang Q; Zhu H
    Pathol Res Pract; 2022 Sep; 237():153941. PubMed ID: 35933883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC.
    Zhou X; Bao W; Zhang D; Yang Y; Du X; Qiu G
    Cancer Biol Ther; 2021 Mar; 22(3):196-203. PubMed ID: 33629937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LINC00649 recruits TAF15 and enhances MAPK6 expression to promote the development of lung squamous cell carcinoma via activating MAPK signaling pathway.
    Zhu H; Liu Q; Yang X; Ding C; Wang Q; Xiong Y
    Cancer Gene Ther; 2022 Aug; 29(8-9):1285-1295. PubMed ID: 35228660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA GMDS-AS1 restrains lung adenocarcinoma progression via recruiting TAF15 protein to stabilize
    Peng W; Jiang J; Fu J; Duan H; Wang J; Duan C
    Epigenomics; 2023 Apr; 15(7):417-434. PubMed ID: 37309595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PITPNA-AS1 abrogates the inhibition of miR-876-5p on WNT5A to facilitate hepatocellular carcinoma progression.
    Sun J; Zhang Y; Li B; Dong Y; Sun C; Zhang F; Jin L; Chen D; Wang W
    Cell Death Dis; 2019 Nov; 10(11):844. PubMed ID: 31700026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.
    Ma J; Qi G; Li L
    Cell Mol Biol Lett; 2020; 25():34. PubMed ID: 32514270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PITPNA-AS1 Inhibits Cell Proliferation and Migration in Ovarian Cancer by Regulating the MIR-223-3p/RHOB Axis.
    Zhang F; Zhang M; Chen Z; Yu B; He X; Luo Y; Ai F; Hu W
    Rev Invest Clin; 2024 May; 76(2):103-115. PubMed ID: 38753591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA PITPNA-AS1 stimulates cell proliferation and suppresses cell apoptosis in glioblastoma via targeting miR-223-3p/EGFR axis and activating PI3K/AKT signaling pathway.
    Geng S; Tu S; Fu W; Wang J; Bai Z
    Cell Cycle; 2021 Oct; 20(19):1988-1998. PubMed ID: 34470587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis.
    Ye P; Lv X; Aizemaiti R; Cheng J; Xia P; Di M
    Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA PITPNA-AS1 promotes cell proliferation and metastasis in hepatocellular carcinoma by upregulating PDGFD.
    Yao J; Liu X
    Aging (Albany NY); 2023 Mar; 15(10):4071-4083. PubMed ID: 37253627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00319 promotes cancer stem cell-like properties in laryngeal squamous cell carcinoma via E2F1-mediated upregulation of HMGB3.
    Yuan L; Tian X; Zhang Y; Huang X; Li Q; Li W; Li S
    Exp Mol Med; 2021 Aug; 53(8):1218-1228. PubMed ID: 34408262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
    Liu B; Chen Y; Yang J
    Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of lncRNA WWTR1-AS1 associates with tumor aggressiveness and unfavorable survival in head-neck squamous cell carcinoma.
    Li J; Li Z; Wu Y; Diao P; Zhang W; Wang Y; Yang J; Cheng J
    J Cell Biochem; 2019 Oct; 120(10):18266-18277. PubMed ID: 31172583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA PITPNA-AS1 promotes cervical cancer progression through regulating the cell cycle and apoptosis by targeting the miR-876-5p/c-MET axis.
    Guo Q; Li L; Bo Q; Chen L; Sun L; Shi H
    Biomed Pharmacother; 2020 Aug; 128():110072. PubMed ID: 32460193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of miR-758 inhibited proliferation, migration, invasion, and promoted apoptosis of non-small cell lung cancer cells by negatively regulating HMGB.
    Zhou GH; Lu YY; Xie JL; Gao ZK; Wu XB; Yao WS; Gu WG
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30446524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and Clinical Significance of lncRNA OSER1-AS1 in Peripheral Blood of Patients with Non-Small Cell Lung Cancer.
    Chen P; Qin Z; Sun X; Yang J; Lv J; Diao M
    Cells Tissues Organs; 2022; 211(5):589-600. PubMed ID: 34525476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USF1-induced upregulation of LINC01048 promotes cell proliferation and apoptosis in cutaneous squamous cell carcinoma by binding to TAF15 to transcriptionally activate YAP1.
    Chen L; Chen Q; Kuang S; Zhao C; Yang L; Zhang Y; Zhu H; Yang R
    Cell Death Dis; 2019 Apr; 10(4):296. PubMed ID: 30931936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.